Table 2. Women with THPO admitted from the ED compared to those with THPO discharged from the ED.

Tubo-ovarian abscess, Hydrosalpinx, Pyosalpinx, and Oophoritis (THPO); Emergency Department (ED); Emergency Severity Index (ESI); White Blood Cells (WBC); High Power Field (HPF); Sexually Transmitted Infection (STI)

	+THPO admitted from ED (N= 28)	+THPO not admitted from ED (N=28)	P-value
Age (years)	31.4 (8.8); 28	37.9 (12.6); 28	.03
Black/African American race, %	92.9% (26/28)	82.1% (23/28)	.23
Single-marital status, %	85.7% (24/28)	78.6% (22/28)	.49
Arrived to ED by EMS/police, %	10.7% (3/28)	28.6% (8/28)	.09
ESI (0-5)	2.9 (.3); 28	3.0 (.2); 27	.32
Triage pain scale (0-10)	6.1 (3.1); 28	7.3 (2.4); 4	.42
Has a primary care physician (vs no), %	28.6% (8/28)	25.0% (7/28)	.76
Vaginal wet prep WBCs >10/HPF (vs ≤10)	50.0% (12/24)	28.6% (6/21)	.14
Vaginal wet prep clue cells, % present	35.0% (7/20)	42.1% (8/19)	.65
Vaginal wet prep yeast cells, % present	5.6% (1/18)	0% (0/18)	.31
Vaginal wet prep trichomonas, % present	21.1% (4/19)	22.2% (4/18)	.93
+gonorrhea	7.7% (2/26)	13.6% (3/22)	.50
+chlamydia	11.5% (3/26)	4.5% (1/22)	.38
+trichomonas	35.7% (5/14)	66.7% (4/6)	.20
+any STI	46.7% (7/15)	83.3% (5/6)	.13
Urine protein (0-3+)	.6 (.8); 28	.9 (1.0); 24	.18
Urine WBCs ≥10 cells/HPF (vs <10)	52.2% (12/23)	47.1% (8/17)	.75
Urine RBCs ≥10 cells/HPF (vs <10)	39.1% (9/23)	50.0% (9/18)	.49
Urine bilirubin (0-3+)	.1 (.4); 28	.4 (.9); 25	.15
Urine leukocyte esterase (0-3+)	.9 (1.1); 26	.8 (1.1); 25	.79
Diagnosed with sepsis, % yes	3.6% (1/28)	3.6% (1/28)	1.0
Diagnosed with pelvic inflammatory disease, % yes	17.9% (5/28)	3.6% (1/28)	.08